AN2 Therapeutics, Inc. — 4 Filings
168 4 filings on record
This page lists all 4 filings submitted to the SEC by AN2 Therapeutics, Inc. (ANTX), sorted by most recent first. Each row links to the full filing on EdgarLookup. AN2 Therapeutics, Inc. has filed 168 4 documents with the SEC since 2021. To view all SEC filings by AN2 Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
144
3
3/A
4
4/A
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-8
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | 4 | 0000950170-25-077053 | May 23, 2025 | May 22, 2025 |
| 4 | 4 | 0000950170-25-077036 | May 23, 2025 | May 22, 2025 |
| 4 | 4 | 0000950170-25-077035 | May 23, 2025 | May 22, 2025 |
| 4 | 4 | 0000950170-25-053373 | Apr 11, 2025 | Apr 10, 2025 |
| 4 | 4 | 0000950170-25-053367 | Apr 11, 2025 | Apr 10, 2025 |
| 4 | 4 | 0000950170-25-053355 | Apr 11, 2025 | Apr 10, 2025 |
| 4 | 4 | 0000950170-25-053348 | Apr 11, 2025 | Apr 10, 2025 |
| 4 | 4 | 0000950170-25-030057 | Feb 28, 2025 | Feb 26, 2025 |
| 4 | 4 | 0000950170-25-030052 | Feb 28, 2025 | Feb 26, 2025 |
| 4 | 4 | 0000950170-25-030042 | Feb 28, 2025 | Feb 26, 2025 |
| 4 | 4 | 0000950170-25-030041 | Feb 28, 2025 | Feb 26, 2025 |
| 4 | 4 | 0000950170-25-030032 | Feb 28, 2025 | Feb 26, 2025 |
| 4 | 4 | 0000950170-25-003160 | Jan 7, 2025 | Jan 3, 2025 |
| 4 | 4 | 0000950170-25-003157 | Jan 7, 2025 | Jan 3, 2025 |
| 4 | 4 | 0000950170-25-003153 | Jan 7, 2025 | Jan 3, 2025 |
| 4 | 4 | 0000950170-25-003152 | Jan 7, 2025 | Jan 3, 2025 |
| 4 | 4 | 0000950170-24-139804 | Dec 23, 2024 | Dec 19, 2024 |
| 4 | 4 | 0000950170-24-139800 | Dec 23, 2024 | Dec 19, 2024 |
| 4 | 4 | 0000950170-24-139797 | Dec 23, 2024 | Dec 19, 2024 |
| 4 | 4 | 0000950170-24-139793 | Dec 23, 2024 | Dec 19, 2024 |
| 4 | 4 | 0000950170-24-139792 | Dec 23, 2024 | Dec 19, 2024 |
| 4 | 4 | 0000950170-24-135150 | Dec 10, 2024 | Dec 6, 2024 |
| 4 | 4 | 0000950170-24-131660 | Nov 27, 2024 | Nov 26, 2024 |
| 4 | 4 | 0000950170-24-131499 | Nov 27, 2024 | — |
| 4 | 4 | 0000950170-24-129830 | Nov 21, 2024 | Nov 19, 2024 |
| 4 | 4 | 0000950170-24-129248 | Nov 20, 2024 | Nov 18, 2024 |
| 4 | 4 | 0000950170-24-128202 | Nov 18, 2024 | — |
| 4 | 4 | 0000950170-24-121601 | Nov 5, 2024 | Nov 4, 2024 |
| 4 | 4 | 0000950170-24-121591 | Nov 5, 2024 | Nov 4, 2024 |
| 4 | — | 0001373604-24-000066 | Aug 14, 2024 | — |
| 4 | — | 0001415889-24-021199 | Aug 13, 2024 | Aug 9, 2024 |
| 4 | 4 | 0000950170-24-083200 | Jul 12, 2024 | Jul 10, 2024 |
| 4 | 4 | 0000950170-24-076410 | Jun 21, 2024 | Jun 19, 2024 |
| 4 | 4 | 0000950170-24-076408 | Jun 21, 2024 | Jun 19, 2024 |
| 4 | 4 | 0000950170-24-076406 | Jun 21, 2024 | Jun 19, 2024 |
| 4 | 4 | 0000950170-24-076404 | Jun 21, 2024 | Jun 19, 2024 |
| 4 | 4 | 0000950170-24-076399 | Jun 21, 2024 | Jun 19, 2024 |
| 4 | 4 | 0000950170-24-076374 | Jun 21, 2024 | Jun 19, 2024 |
| 4 | 4 | 0000950170-24-076369 | Jun 21, 2024 | Jun 19, 2024 |
| 4 | 4 | 0000950170-24-076361 | Jun 21, 2024 | Jun 19, 2024 |
| 4 | — | 0001610717-24-000169 | Mar 18, 2024 | Mar 15, 2024 |
| 4 | — | 0001610717-24-000168 | Mar 18, 2024 | Mar 15, 2024 |
| 4 | — | 0001610717-24-000167 | Mar 18, 2024 | Mar 15, 2024 |
| 4 | — | 0001610717-24-000166 | Mar 18, 2024 | Mar 15, 2024 |
| 4 | — | 0001610717-24-000165 | Mar 18, 2024 | Mar 15, 2024 |
| 4 | — | 0001610717-24-000164 | Mar 18, 2024 | Mar 15, 2024 |
| 4 | 4 | 0000950170-24-005900 | Jan 19, 2024 | Jan 18, 2024 |
| 4 | 4 | 0000950170-24-005515 | Jan 18, 2024 | Jan 16, 2024 |
| 4 | 4 | 0000950170-24-005513 | Jan 18, 2024 | Jan 16, 2024 |
| 4 | FORM 4 SUBMISSION | 0001209191-24-001770 | Jan 17, 2024 | Jan 12, 2024 |